A 12-month longitudinal naturalistic follow-up of cariprazine in schizophrenia

Bibliographic Data

ID15526854
AuthorsClaudia Carmassi (0000-0002-3662-8073, University of Pisa), Valerio Dell’Oste (0000-0003-0520-4785, University of Pisa, corresponding author), Sara Fantasia (University of Pisa), Andrea Bordacchini (University of Pisa), Carlo Antonio Bertelloni (0000-0003-1752-0339, University of Pisa), Pietro Scarpellini, Virginia Pedrinelli (0000-0002-3105-893X, University of Siena)
Year2024
Volume15
Pages1382013-1382013
Publication date2024-05-21
Peer ReviewedYes
Open AccessYes
TypeARTICLE
VenueFrontiers in Psychiatry (JOURNAL)
Journal identifiersISSN: 1664-0640 • E-ISSN: 1664-0640
PublisherFrontiers Media (PUBLISHER • CH)
DOI10.3389/fpsyt.2024.1382013
PMID38835554
OpenAlexW4398174411
LanguageEN
Citations received1
References cited34

This study confirms a good efficacy profile of cariprazine in both positive and negative symptoms in patients with Schizophrenia, combined with a good tolerability profile in extrapyramidal symptoms

Naturalistic observation · Psychiatry · Psychotherapist · Schizophrenia (object-oriented programming · Medicine · Neurotransmitter Receptor Influence on Behavior · Obsessive-Compulsive Spectrum Disorders · Psychology · Schizophrenia research and treatment · Social Psychology

Tools

Open DOIOpen Access